We're an interdisciplinary, collaborative team with a mission to transform protein therapeutics discovery.
Gleb Kuznetsov, PhD
Co-Founder & CEO
PhD, Harvard Biophysics
Pierce Ogden, PhD
Co-Founder & CSO
PhD, Harvard Biological Sciences
Shane Lofgren
Co-Founder & Head of Business Development
Bioinformatics, Stanford / MD Anderson
George Church, PhD
Co-Founder
Professor, Harvard / MIT
Kate Nudel, PhD
Associate Director, Head of Applied Biology
Postdoctoral Fellow, Brigham and Women's PhD, Boston University Molecular Medicine
Hoong Chuin Lim, PhD
Associate Director, Head of Barcoding Platform
Postdoctoral Fellow, Harvard Medical School PhD, Yale Molecular Biophysics and Biochemistry
Anisha Anand
Senior Research Associate
BS, Purdue Biotechnology
Karen Duffy, PhD
Senior Scientist
PhD, MRC Laboratory of Molecular Biology Gates Cambridge Scholar
Alex Reis, PhD
Senior Scientist
PhD, Penn State University
Alvaro García, PhD
Senior Scientist
Assistant Professor of Clinical Neurobiology in Psychiatry, Columbia PhD, University of Navarra Neuropsychopharmacology
John Avera
Scientist
BS, Indiana University Microbiology, Japanese
Roasa Mehmood
Associate Scientist
MS, USC Biochemistry and Molecular Medicine
Molly Zawacki
Operations Associate
BSE, UPenn Chemical and Biomolecular Engineering
Mike Nichols, PhD
Scientist
Data Scientist, PhD in Genomics
Anca Ioana Stoica
Research Associate
No longer a field
Supriya Ravichandran
Scientist
Not needed anymore
Sal Alioto
Principal Scientist
Not applicable anymore
.jpg)
Fabliha Anam
Research Associate
Not applicable anymore
Jeffrey Chang
Biophysics / Statistical Modeling Consultant
Harvard PhD Candidate
Alex Lugovskoy, PhD
SAB, Protein Therapeutics Discovery and Development
EIR, Atlas Venture
Dennis Benjamin, PhD
SAB, Protein Therapeutics Discovery and Development
N/A
Seth Ettenberg, PhD
Strategic Advisor, Platform Build and Partnering
CEO, Bluerock Therapeutics
Ryan P. Adams, PhD
SAB, Machine Learning-guided Design
Professor of Computer Science, Princeton
Eliezer Van Allen, MD
SAB, Oncology Indication Selection and Target ID
Professor of Medicine, Harvard Medical School Clinical Oncologist, Dana Farber Cancer Institute
